Canada markets close in 2 hours 45 minutes

Leap Therapeutics, Inc. (LPTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.1300-0.0400 (-1.26%)
As of 01:08PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 80.14M
Enterprise Value 9.76M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)160.10
Price/Book (mrq)1.33
Enterprise Value/Revenue -66.81
Enterprise Value/EBITDA -0.12

Trading Information

Stock Price History

Beta (5Y Monthly) 0.59
52-Week Change 3-18.51%
S&P500 52-Week Change 322.43%
52 Week High 310.2000
52 Week Low 31.2350
50-Day Moving Average 32.7727
200-Day Moving Average 32.5133

Share Statistics

Avg Vol (3 month) 3309k
Avg Vol (10 day) 3195.88k
Shares Outstanding 525.6M
Implied Shares Outstanding 625.6M
Float 819.85M
% Held by Insiders 115.88%
% Held by Institutions 125.16%
Shares Short (Apr 15, 2024) 41.45M
Short Ratio (Apr 15, 2024) 42.75
Short % of Float (Apr 15, 2024) 45.84%
Short % of Shares Outstanding (Apr 15, 2024) 45.67%
Shares Short (prior month Mar 15, 2024) 41.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jun 21, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-75.03%
Return on Equity (ttm)-136.82%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -85.92M
Net Income Avi to Common (ttm)-81.41M
Diluted EPS (ttm)-3.9800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)70.64M
Total Cash Per Share (mrq)2.76
Total Debt (mrq)262k
Total Debt/Equity (mrq)0.44%
Current Ratio (mrq)5.64
Book Value Per Share (mrq)2.35

Cash Flow Statement

Operating Cash Flow (ttm)-43.75M
Levered Free Cash Flow (ttm)-46.85M